Target intelligence / Profile preview

Ribosomal protein L23a pseudogene 88 (RPL23AP88)

Target
RPL23AP88
Molecular classification
Other
01

Overview

Ribosomal protein L23a pseudogene 88 (RPL23AP88) is a processed pseudogene, meaning it resembles the ribosomal protein L23a gene but does not encode a functional protein. Pseudogenes like RPL23AP88 generally lack protein-coding capacity and are not considered classic therapeutic targets, receptors, enzymes, or similar druggable entities. There is no evidence that RPL23AP88 is involved in canonical biological functions, diseases, or drug interactions. Its primary classification is as a non-functional genomic sequence originating from the ribosomal protein L23a gene family[1]. \n\nNote: It is possible you meant another member of the ribosomal protein L23a pseudogene family, such as RPL23AP53, which has some described associations with cancer biology, but RPL23AP88 itself is specifically classified as a pseudogene and not a protein-coding or functional therapeutic target[1].

Other names
RPL23AP88
02

Biological functions

Other
03

Disease associations

Other

Beyond the preview

Go deeper on Ribosomal protein L23a pseudogene 88 (RPL23AP88).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L23a pseudogene 88 (RPL23AP88).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call